miRagen Therapeutics
MGEN
#9333
Rank
A$0.12 B
Marketcap
A$32.61
Share price
-0.09%
Change (1 day)
N/A
Change (1 year)

Earnings for miRagen Therapeutics (MGEN)

Earnings in 2020 (TTM): -A$43.81 Million

According to miRagen Therapeutics's latest financial reports the company's current earnings are A$2.57 Million. In 2019 the company made an earning of -A$58.17 Million a decrease over its 2018 earnings that were of -A$45.12 Million.

Earnings history for miRagen Therapeutics from 2013 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-A$43.81 Million-24.68%
2019-A$58.17 Million28.93%
2018-A$45.12 Million21.82%
2017-A$37.04 Million107.72%
2016-A$17.83 Million12.44%
2015-A$15.86 Million62.91%
2014-A$9.74 Million3399.77%
2013-A$0.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ocular Therapeutix
OCUL
-A$0.36 Billion 743.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Oragenics
OGEN
-A$14.34 Million-65.82%๐Ÿ‡บ๐Ÿ‡ธ USA
OncoCyte
OCX
-A$82.5 Million 96.69%๐Ÿ‡บ๐Ÿ‡ธ USA